EVMN EBITDA Growth

Evommune, Inc. Common Stock · EBITDA Growth

EVMN logo

EVMN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-63.15%
EVMN TTM EBITDA YoY % (-9.53% → -63.15%)
High-resolution chart · PNG

EVMN ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Evommune, Inc. Common Stock EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-63.1523%
-5.0789%
-9.5342%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.